Further, targeted inhibition of FOXM1 either by siRNA or thiostrepton was recently reported to sensitize DLBCL cells to killing when combined with normally sub-toxic doses of the proteasome inhibitor bortezomib [39]. The gene discussed is FOXM1; the disease is diffuse large B-cell lymphoma.